Mouwasat Medical Services Company (4002.SE)

Also known as:  Mouwasat
Data delayed by 15 minutes
132.20 SAR -4.00-2.94%
As of 26 OCT 2020 12:16 GMT|Saudi SE

Mouwasat Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
31.3
Upside
-
Target Price (Mean)
-
52Wk
68.3 23 MAR
143.0 08 OCT

Open
130.20 SAR
Previous Close
132.20 SAR
Turnover
19.41M SAR
EPS
4.473 SAR
Volume
145,415
Transactions
713
Market Cap
13.22B SAR
IPO Date
02-Sep-2009
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Mouwasat Medical Services CompanyLast updated on: 28 March 2020

Business Summary
Ownership and operation of hospitals, clinics, medical centers and pharmacies.
Country of Incorporation
Ownership Type
Established In
1997
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
4002.SSEOrdinarySARSaudi SE4002

Contact details

Primary address
Mouwasat Medical Services Company, Block 71
King Fahad Road
Uhod District
282
Saudi Arabia
Dammam
31411
CONTACT
  • Tel: +966 13-820-0000
  • Tel: +966 13-820-0016
  • Fax: +966 13-820-3436
  • Fax: +966 13-820-0014
  • Email: www.mouwasat.com
Region
Eastern Province
More
All Press Releases
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Naser Sultan Fahad Al Subaie
Chief Executive Officer
Mr Mohammed Bin Suleiman Mohammed Al Saleem
Managing Director
Mr Khalid Bin Suleiman Mohammed Al Saleem
Deputy Managing Director

Board Members

Mr Mohammed Sultan Hamad Al Subaie
Chairman
Mr Naser Sultan Fahad Al Subaie
Vice Chairman
Mr Mohammed Bin Suleiman Mohammed Al Saleem
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
PHARMACEUTICALS34.200 SAR1.18
SAUDI GERMAN HSP34.900 SAR1.60
AL HAMMADI CO29.200 SAR6.18
SULAIMAN ALHABIB96.300 SAR2.45
DALLAH HEALTH46.400 SAR4.62
More

Monday Outlook: Dollar firms over new U.S. coronavirus aid package; oil prices drop

Monday Outlook: Dollar firms over new U.S. coronavirus aid package; oil prices drop

US has recorded its highest ever number of new COVID-19 cases for two consecutive days

More

Most Viewed Stocks

Stock Screener

More